glucagon has been researched along with n-oleoylethanolamine in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (n-oleoylethanolamine) | Trials (n-oleoylethanolamine) | Recent Studies (post-2010) (n-oleoylethanolamine) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 436 | 17 | 281 |
Protein | Taxonomy | glucagon (IC50) | n-oleoylethanolamine (IC50) |
---|---|---|---|
Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 3.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cani, PD; Delzenne, NM; Lambert, DM; Montoya, ML; Neyrinck, AM | 1 |
1 other study(ies) available for glucagon and n-oleoylethanolamine
Article | Year |
---|---|
Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
Topics: Animals; Appetite Regulation; Blood Glucose; Blotting, Western; Cannabinoids; Eating; Endocannabinoids; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Male; Oleic Acids; Peptide Fragments; Peptide Hormones; Piperidines; Protein Precursors; Pyrazoles; Rats; Rats, Wistar; Receptors, Drug; Rimonabant | 2004 |